Fundz

Who to call at OnKure Therapeutics, and when

Fundz watches for the moments OnKure Therapeutics starts buying, and tells you who to reach.

  • An alert the day OnKure Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OnKure Therapeutics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchOnKure Therapeutics, Inc. announces presentation of clinical and preclinical data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium.

Nov 01, 2024
BoulderBiotechnologyHealthcareTherapeuticsPharmaceuticalBiopharma

Product Description

OnKure Therapeutics, Inc. will present two abstracts discussing preliminary clinical and preclinical data for their drug OKI-219 at the upcoming San Antonio Breast Cancer Symposium. The conference call to review key data will take place on December 13, 2024.

Company Information

Company

OnKure Therapeutics

Location

6707 WINCHESTER CIRCLE

Boulder, Colorado, United States

About

OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of best-in-class precision medicines that target biologically significant and well-validated pharmacological pathways, with a focus on oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OnKure Therapeutics ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Samuel hidden

hidden
hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for OnKure Therapeutics's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

OnKure Therapeutics shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.